retatrutide que es Retatrutida permite perder hasta 30 % del peso, según estudio- UCHealth Today Retatrutide Contraindications: Risks and Considerations

For an industry built on volume and operating on thin margins, this is material

Wegovy en pastillas fue aprobado por la EMA (Agencia Europea de Medicamentos) en julio de 2026 y se estima que lleguen a Espaa pronto

A large real-world study shows that patients who stop popular GLP-1based weight-loss drugs often return to treatment or try alternative therapies, helping explain why average weight regain after discontinuation may be smaller than expected

Many are actively seeking sustainable, long-term solutions to maintain their progress and we aim to support that need. Scientific studies investigating whether GLP-1 stimulating foods can support weight loss in the longer term are lacking, or at least, the right ones are, says Dr Edwards

Each capsule is crafted with quality in mind, ensuring a pure and effective dose that aligns with your health goals

For a deeper dive into these topics, watch the webinar on-demand here.